Male contraceptive pill shown to be safe and tolerable in phase I trial

A potential new male birth control pill has been declared safe for use after a phase-one trial showed that the once-daily capsule seemed to work without causing any significant side effects.

The male contraceptive pill has been shown to be safe - picture shows man taking pillsMonika Gruszewicz | Shutterstock

The trial investigators say the pill may be available to use within a decade. The drug aims to suppress the hormones that drive sperm production, whilst preserving libido and enabling reversal of the effect once men stop taking the treatment.

The goal is to expand contraceptive options and create a menu of choices for men like we have for women. We are neglecting a major potential user population with the limited options currently available to men.”

Stephanie Page, Co-senior Investigator

For the study, Page and colleagues invited forty healthy men to participate in a trial at the University of Washington and Los Angeles Biomed Research Institute, where the drug is being developed.

Ten participants were given a placebo and the remaining 30 received a 200mg or 400mg dose of the drug, 11-beta-MNTDC. The formulation contains a type of progesterone that blocks the hormone LH, which is needed for testosterone production in the testes and the hormone FSH, which works together with testosterone to make sperm.

It also contains an androgen hormone that counteracts the resulting drop in testosterone: “Since testosterone production is shut down in the testes, the androgen action in the rest of the body maintains ‘maleness’ elsewhere, supporting things like male pattern hair, deep voice, sex drive and function, and lean body mass,” explains Page.

Capsules were taken once a day with food over a 28-day period, at which point the experiment was stopped so that safety and tolerability could be assessed.

As reported in the Journal of Clinical Endocrinology and Metabolism, Page and team found that LH and FSH levels were significantly reduced among those who took the drug, compared with those who took a placebo, suggesting that the drug had stopped sperm production. Furthermore, lead researcher, Christina Wang, says the effects exerted by the drug were reversible once treatment was stopped.

None of the participants dropped out or found they had less sex during the trial, but some did report mild side-effects including headaches, acne, tiredness, and a slightly decreased libido. Two men also reported having mild erectile dysfunction, although they did not report any decrease in sexual activity.

The Family Planning Association has called the development as a step in the right direction, welcoming any new method of contraception that allows men to take greater responsibility for male contraception: “We believe lots of men would be interested in trying new methods of contraception that will allow them to ease the burden of responsibility for their partners.”

Wang says the next step is to measure the fall in sperm production directly to confirm the decrease and determine whether it is sufficient:

This study is very short and we need three months if not more to stop sperm production. All we have shown so far is that it shuts down the hormones that control the function of the testes.”

Stephanie Wang, Lead Researcher

The researchers say it could be a decade before a male pill becomes available on the market, but that they believe there is strong demand from couples: “When we ask men about hormonal compounds, about 50% are willing to try this new method. And when you ask their partners, the percentage is even higher,” says Wang.

Source:
Sally Robertson

Written by

Sally Robertson

Sally has a Bachelor's Degree in Biomedical Sciences (B.Sc.). She is a specialist in reviewing and summarising the latest findings across all areas of medicine covered in major, high-impact, world-leading international medical journals, international press conferences and bulletins from governmental agencies and regulatory bodies. At News-Medical, Sally generates daily news features, life science articles and interview coverage.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2019, June 19). Male contraceptive pill shown to be safe and tolerable in phase I trial. News-Medical. Retrieved on August 20, 2019 from https://www.news-medical.net/news/20190326/Male-contraceptive-pill-shown-to-be-safe-and-tolerable-in-phase-I-trial.aspx.

  • MLA

    Robertson, Sally. "Male contraceptive pill shown to be safe and tolerable in phase I trial". News-Medical. 20 August 2019. <https://www.news-medical.net/news/20190326/Male-contraceptive-pill-shown-to-be-safe-and-tolerable-in-phase-I-trial.aspx>.

  • Chicago

    Robertson, Sally. "Male contraceptive pill shown to be safe and tolerable in phase I trial". News-Medical. https://www.news-medical.net/news/20190326/Male-contraceptive-pill-shown-to-be-safe-and-tolerable-in-phase-I-trial.aspx. (accessed August 20, 2019).

  • Harvard

    Robertson, Sally. 2019. Male contraceptive pill shown to be safe and tolerable in phase I trial. News-Medical, viewed 20 August 2019, https://www.news-medical.net/news/20190326/Male-contraceptive-pill-shown-to-be-safe-and-tolerable-in-phase-I-trial.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post